Literature DB >> 19582739

Multiple tissue-specific isoforms of sulfatide activate CD1d-restricted type II NKT cells.

Maria Blomqvist1, Sara Rhost, Susann Teneberg, Linda Löfbom, Thomas Osterbye, Manfred Brigl, Jan-Eric Månsson, Susanna L Cardell.   

Abstract

The glycosphingolipid sulfatide (SO(3)-3Galbeta1Cer) is a demonstrated ligand for a subset of CD1d-restricted NKT cells, which could regulate experimental autoimmune encephalomyelitis, a murine model for multiple sclerosis, as well as tumor immunity and experimental hepatitis. Native sulfatide is a mixture of sulfatide isoforms, i.e. sulfatide molecules with different long-chain bases and fatty acid chain lengths and saturation. Here, we demonstrate that sulfatide-specific CD1d-restricted murine NKT hybridomas recognized several different sulfatide isoforms. These included the physiologically relevant isoforms C24:1 and C24:0, major constituents of the myelin sheet of the nervous system, and C16:0, prominent in the pancreatic islet beta-cells. The most potent sulfatide isoform was lysosulfatide (lacking a fatty acid). Shortened fatty acid chain length (C24:1 versus C18:1), or saturation of the long fatty acid (C24:0), resulted in reduced stimulatory capacity, and fatty acid hydroxylation abolished the response. Moreover, sulfatide was not responsible for the natural autoreactivity toward splenocytes by XV19 T hybridoma cells. Our results reveal a promiscuity in the recognition of sulfatide isoforms by a CD1d-restricted NKT-cell clone, and suggest that sulfatide, a major component of the myelin sheet and pancreatic beta-cells, is one of several natural ligands for type II CD1d-restricted NKT cells.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19582739      PMCID: PMC4212524          DOI: 10.1002/eji.200839001

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  56 in total

1.  Structural features of the acyl chain determine self-phospholipid antigen recognition by a CD1d-restricted invariant NKT (iNKT) cell.

Authors:  Joyce Rauch; Jenny Gumperz; Cheryl Robinson; Markus Sköld; Chris Roy; David C Young; Michel Lafleur; D Branch Moody; Michael B Brenner; Catherine E Costello; Samuel M Behar
Journal:  J Biol Chem       Date:  2003-09-08       Impact factor: 5.157

Review 2.  NKT cells: what's in a name?

Authors:  Dale I Godfrey; H Robson MacDonald; Mitchell Kronenberg; Mark J Smyth; Luc Van Kaer
Journal:  Nat Rev Immunol       Date:  2004-03       Impact factor: 53.106

Review 3.  CD1 antigen presentation: how it works.

Authors:  Duarte C Barral; Michael B Brenner
Journal:  Nat Rev Immunol       Date:  2007-12       Impact factor: 53.106

4.  Preparation of total nonacid glycolipids for overlay analysis of receptors for bacteria and viruses and for other studies.

Authors:  K A Karlsson
Journal:  Methods Enzymol       Date:  1987       Impact factor: 1.600

5.  CD1.1 expression by mouse antigen-presenting cells and marginal zone B cells.

Authors:  J H Roark; S H Park; J Jayawardena; U Kavita; M Shannon; A Bendelac
Journal:  J Immunol       Date:  1998-04-01       Impact factor: 5.422

6.  CD1d-specific NK1.1+ T cells with a transgenic variant TCR.

Authors:  M Sköld; N N Faizunnessa; C R Wang; S Cardell
Journal:  J Immunol       Date:  2000-07-01       Impact factor: 5.422

7.  Prevention of diabetes in nonobese diabetic mice mediated by CD1d-restricted nonclassical NKT cells.

Authors:  Nadia Duarte; Martin Stenström; Susana Campino; Marie-Louise Bergman; Marie Lundholm; Dan Holmberg; Susanna L Cardell
Journal:  J Immunol       Date:  2004-09-01       Impact factor: 5.422

8.  Ganglioside composition in human meningiomas.

Authors:  P Davidsson; P Fredman; V P Collins; H von Holst; J E Mänsson; L Svennerholm
Journal:  J Neurochem       Date:  1989-09       Impact factor: 5.372

9.  Establishment of mouse cell lines which constitutively secrete large quantities of interleukin 2, 3, 4 or 5, using modified cDNA expression vectors.

Authors:  H Karasuyama; F Melchers
Journal:  Eur J Immunol       Date:  1988-01       Impact factor: 5.532

10.  Presentation of the same glycolipid by different CD1 molecules.

Authors:  A Shamshiev; H-J Gober; A Donda; Z Mazorra; L Mori; G De Libero
Journal:  J Exp Med       Date:  2002-04-15       Impact factor: 14.307

View more
  57 in total

1.  Oligoclonality and innate-like features in the TCR repertoire of type II NKT cells reactive to a beta-linked self-glycolipid.

Authors:  Philomena Arrenberg; Ramesh Halder; Yang Dai; Igor Maricic; Vipin Kumar
Journal:  Proc Natl Acad Sci U S A       Date:  2010-06-01       Impact factor: 11.205

2.  CD1d-restricted NKT cells modulate placental and uterine leukocyte populations during chlamydial infection in mice.

Authors:  Mohamed Habbeddine; Philippe Verbeke; Christiane Delarbre; René Moutier; Stéphane Prieto; David M Ojcius; Colette Kanellopoulos-Langevin
Journal:  Microbes Infect       Date:  2013-08-31       Impact factor: 2.700

Review 3.  T cells specific for lipid antigens.

Authors:  Lucia Mori; Gennaro De Libero
Journal:  Immunol Res       Date:  2012-09       Impact factor: 2.829

4.  Regulation of memory CD4 T-cell pool size and function by natural killer T cells in vivo.

Authors:  Chiaki Iwamura; Kenta Shinoda; Yusuke Endo; Yukiko Watanabe; Damon John Tumes; Shinichiro Motohashi; Kazuyoshi Kawahara; Yuki Kinjo; Toshinori Nakayama
Journal:  Proc Natl Acad Sci U S A       Date:  2012-10-01       Impact factor: 11.205

Review 5.  Natural Killer T cell obsession with self-antigens.

Authors:  Laurent Gapin; Dale I Godfrey; Jamie Rossjohn
Journal:  Curr Opin Immunol       Date:  2013-02-04       Impact factor: 7.486

6.  Polyclonal type II natural killer T cells require PLZF and SAP for their development and contribute to CpG-mediated antitumor response.

Authors:  Jie Zhao; Xiufang Weng; Sreya Bagchi; Chyung-Ru Wang
Journal:  Proc Natl Acad Sci U S A       Date:  2014-02-03       Impact factor: 11.205

Review 7.  Coevolution of T-cell receptors with MHC and non-MHC ligands.

Authors:  Caitlin D Castro; Adrienne M Luoma; Erin J Adams
Journal:  Immunol Rev       Date:  2015-09       Impact factor: 12.988

8.  CD1d expression in paneth cells and rat exocrine pancreas revealed by novel monoclonal antibodies which differentially affect NKT cell activation.

Authors:  Elisa Monzon-Casanova; Birte Steiniger; Stefanie Schweigle; Holger Clemen; Daniela Zdzieblo; Lisa Starick; Ingrid Müller; Chyung-Ru Wang; Sara Rhost; Susanna Cardell; Elwira Pyz; Thomas Herrmann
Journal:  PLoS One       Date:  2010-09-30       Impact factor: 3.240

Review 9.  Regulatory B lymphocyte functions should be considered in chronic lymphocytic leukemia.

Authors:  Audrey Mohr; Yves Renaudineau; Cristina Bagacean; Jacques-Olivier Pers; Christophe Jamin; Anne Bordron
Journal:  Oncoimmunology       Date:  2016-03-16       Impact factor: 8.110

Review 10.  Recognition of CD1d-restricted antigens by natural killer T cells.

Authors:  Jamie Rossjohn; Daniel G Pellicci; Onisha Patel; Laurent Gapin; Dale I Godfrey
Journal:  Nat Rev Immunol       Date:  2012-11-16       Impact factor: 53.106

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.